SLC2A1 and neoplasm: In this model, logistic regression analyses demonstrated that clinical parameters (age, gender, and tumor stage) and core molecules (SLC2A1, TLE1, FAM83A, HMGA2, FBXO44, and MTRNR2L12) contributed differently to LUAD scores at different stages.